医疗事务声誉（美国）：异位性皮肤炎

本报告基于美国皮肤科医生的回馈，分析了支持异位性皮肤炎药物的医疗事务团队的竞争力和声誉。报告深入分析了医生与医疗事务团队的互动方式、哪些服务最重要、各产品的满意度以及医生偏好的沟通管道和频率。报告还指出了医疗事务团队需要加强能力的领域，以便在未来的治疗环境中更好地满足医生的需求。

关键问题

• 1.医师与医疗事务团队的互动频率如何？这种频率是增加了还是减少了？
• 2.医师目前如何利用医疗事务团队提供的服务？
• 3.哪些医疗事务支援对医师最重要？他们对这种支持的满意度如何？
• 4.医师喜欢如何与医疗事务团队互动？他们喜欢多久互动一次？
• 5.医学事务团队如何满足医师的需求？
• 6.对于特定品牌，医学事务团队的表现是否超出预期或低于预期？
• 7.如何改善医学事务服务，以便未来能更好地满足医师的需求？
• 8.竞争对手的医学事务团队有哪些优点和缺点？

领导品牌

This report examines the competitive performance and reputation of Medical Affairs teams supporting therapies for atopic dermatitis, based on feedback from dermatologists in the US. It provides detailed insights into how physicians currently engage with Medical Affairs teams, the services they value most, satisfaction levels by product, and preferred channels and frequency of interaction. The findings also highlight areas where Medical Affairs teams can strengthen their support to better meet physician needs in an evolving treatment landscape.

Key Questions Answered:

• 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
• 2. In what ways do physicians currently use the services provided by Medical Affairs teams?
• 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
• 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
• 5. How successful are Medical Affairs teams at meeting physician needs?
• 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
• 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
• 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.